^
Association details:
| Biomarker: | HER-2 positive |
|---|---|
| Cancer: | HER2 Positive Breast Cancer |
| Drug: | GCC2003 (HER2 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
129 Development of AB-201, a novel allogeneic anti-HER2-specific CAR-NK cell therapy for the treatment of HER2+ tumors
Published date:
11/09/2021
Excerpt:
Data presented herein suggests that AB-201, a highly pure and readily expandable HER2-directed CAR NK cell product, has potential to be an effective therapy in the treatment of HER2+ tumors.
DOI:
http://dx.doi.org/10.1136/jitc-2021-SITC2021.129
